Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells

Tamami Yasukagawa, Yuki Niwa, Siro Simizu, Kazuo Umezawa

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

It has been demonstrated that potassium channels (K + channels) play significant roles in some malignant phenotypes. Here, we provide the first evidence that treatment with glybenclamide, an ATP-sensitive K + channel blocker, inhibited cell migration in an ovarian clear cell carcinoma cell line, ES-2. Treatment with glybenclamide or knockdown by siRNA targeted against K + channel subunits demonstrated the suppression of ovarian cancer cell invasion, which occurred via inhibition of PDGF-AA secretion. Therefore, our findings suggest that K + channel blockers may be useful chemotherapeutic drugs for blocking the invasiveness of ovarian cancers.

Original languageEnglish
Pages (from-to)1504-1509
Number of pages6
JournalFEBS Letters
Volume586
Issue number10
DOIs
Publication statusPublished - 2012 May 21

Fingerprint

Glyburide
Platelet-Derived Growth Factor
Ovarian Neoplasms
Cells
Carcinoma
Potassium Channels
Small Interfering RNA
Cell Movement
Adenosine Triphosphate
Phenotype
Cell Line
Pharmaceutical Preparations
platelet-derived growth factor A

Keywords

  • Glybenclamide
  • Ovarian cancer
  • Platelet-derived growth factor
  • Potassium channel
  • Trafficking
  • Tumor invasion

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Structural Biology

Cite this

Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells. / Yasukagawa, Tamami; Niwa, Yuki; Simizu, Siro; Umezawa, Kazuo.

In: FEBS Letters, Vol. 586, No. 10, 21.05.2012, p. 1504-1509.

Research output: Contribution to journalArticle

@article{584ba34267a04ac7b36b590fdf698231,
title = "Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells",
abstract = "It has been demonstrated that potassium channels (K + channels) play significant roles in some malignant phenotypes. Here, we provide the first evidence that treatment with glybenclamide, an ATP-sensitive K + channel blocker, inhibited cell migration in an ovarian clear cell carcinoma cell line, ES-2. Treatment with glybenclamide or knockdown by siRNA targeted against K + channel subunits demonstrated the suppression of ovarian cancer cell invasion, which occurred via inhibition of PDGF-AA secretion. Therefore, our findings suggest that K + channel blockers may be useful chemotherapeutic drugs for blocking the invasiveness of ovarian cancers.",
keywords = "Glybenclamide, Ovarian cancer, Platelet-derived growth factor, Potassium channel, Trafficking, Tumor invasion",
author = "Tamami Yasukagawa and Yuki Niwa and Siro Simizu and Kazuo Umezawa",
year = "2012",
month = "5",
day = "21",
doi = "10.1016/j.febslet.2012.04.007",
language = "English",
volume = "586",
pages = "1504--1509",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells

AU - Yasukagawa, Tamami

AU - Niwa, Yuki

AU - Simizu, Siro

AU - Umezawa, Kazuo

PY - 2012/5/21

Y1 - 2012/5/21

N2 - It has been demonstrated that potassium channels (K + channels) play significant roles in some malignant phenotypes. Here, we provide the first evidence that treatment with glybenclamide, an ATP-sensitive K + channel blocker, inhibited cell migration in an ovarian clear cell carcinoma cell line, ES-2. Treatment with glybenclamide or knockdown by siRNA targeted against K + channel subunits demonstrated the suppression of ovarian cancer cell invasion, which occurred via inhibition of PDGF-AA secretion. Therefore, our findings suggest that K + channel blockers may be useful chemotherapeutic drugs for blocking the invasiveness of ovarian cancers.

AB - It has been demonstrated that potassium channels (K + channels) play significant roles in some malignant phenotypes. Here, we provide the first evidence that treatment with glybenclamide, an ATP-sensitive K + channel blocker, inhibited cell migration in an ovarian clear cell carcinoma cell line, ES-2. Treatment with glybenclamide or knockdown by siRNA targeted against K + channel subunits demonstrated the suppression of ovarian cancer cell invasion, which occurred via inhibition of PDGF-AA secretion. Therefore, our findings suggest that K + channel blockers may be useful chemotherapeutic drugs for blocking the invasiveness of ovarian cancers.

KW - Glybenclamide

KW - Ovarian cancer

KW - Platelet-derived growth factor

KW - Potassium channel

KW - Trafficking

KW - Tumor invasion

UR - http://www.scopus.com/inward/record.url?scp=84861202114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861202114&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2012.04.007

DO - 10.1016/j.febslet.2012.04.007

M3 - Article

VL - 586

SP - 1504

EP - 1509

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 10

ER -